Inhibition of FZD7 using a dominant negative extracellular domain is able to block the growth of human colon cancer cells in vitro and in xenograft experiments with stably transfected SK-CO-1 cells, which harbour mutations to APC [84]. Here, APC is linked to colonic neoplasm.